Evidence map›Paper›PMID 41044469›Full record

ArticleMolecular imaging and biology2025

Metabolic Shift Mirrors GBM Immunity to Anti-PD-L1 Immunotherapy: A Deuterium MRS Study.

Joel R Garbow, Xia Ge, Tanner M Johanns, John A Engelbach, Keith M Rich, Joseph J H Ackerman

Abstract read
In one paragraph

Article in Molecular imaging and biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joel R GarbowDepartment of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA. garbow@wustl.edu.ORCID 0000-0002-0654-2703
Xia GeDepartment of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Tanner M JohannsDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
John A EngelbachDepartment of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Keith M RichDepartment of Neurosurgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Joseph J H AckermanDepartment of Radiology, Washington University School of Medicine, St. Louis, MO, 63110, USA.

Funding

Imaging and Targeted Auger Radiotherapy of High-Grade GliomaR01EB029752 · NIBIB · WASHINGTON UNIVERSITY · PI GARBOW, JOEL RICHARD, ROGERS, BUCK E. · 2020 to 2023
$3.1M
Alvin J. Siteman Cancer Center Small-Animal Cancer Imaging Shared ResourceMallinckrodt Institute of Radiology Pilot Fund ProgramMallinckrodt Institute of Radiology Small-Animal Magnetic Resonance FacilityNIBIB NIH HHS R01 EB029752NIH HHS R01 EB029752
6 · The paper itself

Abstract

BACKGROUND/

objectivesImmune checkpoint blockade (ICB) therapy has been ineffective in glioblastoma (GBM) that recurs following standard-of-care resection and chemoradiation of the primary tumor. Herein, we investigate whether the delayed effect of intracranial radiation alters the tumor lesion metabolic profile.

methodsNaïve (non-irradiated) GL261 tumor cells were implanted into the brains of C57BL/6 mice. Brains of one cohort were hemispherically irradiated six weeks prior to implantation, ultimately resulting in ICB refractory GBM. Brains of the control cohort were not irradiated. Following subcutaneous infusion of [6,6-

resultsGL261 tumors growing in previously irradiated brain showed reduced Warburg effect (aerobic glycolysis; glucose → lactate) and greater TCA cycle activity (respiration, oxidative phosphorylation) relative to tumors growing in non-irradiated brain as evidenced by cohort differences in the ratios Glx/Lac (p < 0.01), Glx/Glc (p < 0.02), and Lac/Glc (p < 0.01).

conclusionsA metabolic program skewed toward oxidative phosphorylation and away from glycolysis has been associated with immune dysfunction. This study documents such a skewed metabolic state in ICB refractory GL261 GBM growing in irradiated brain (tumors were not irradiated) compared to control brain.

Indexed as

B7-H1 AntigenBrain NeoplasmsDeuteriumGlioblastomaImmune Checkpoint InhibitorsImmunotherapyAnimalsCell Line, TumorGlucoseHumansLactic AcidMagnetic Resonance SpectroscopyMiceMice, Inbred C57BLB7-H1 AntigenDeuteriumGlucoseImmune Checkpoint InhibitorsLactic AcidCheckpoint inhibitorsDeuteriumImmunotherapyMicroenvironmentMRIMRSRadiationTumor

Identifiers

PMID41044469
PMCPMC12804334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.